Noradrenaline/dopamine/serotonin reuptake

Class

Triple monoamine reuptake inhibitor

This mechanism targets three membrane proteins that clear neurotransmitters from the synaptic space after release: the norepinephrine transporter, the dopamine transporter, and the serotonin transporter. Under normal signaling, a neuron releases one of these monoamines, it binds receptors on a neighboring cell, and the transporter then pulls the molecule back into the releasing neuron, ending the signal. A triple reuptake inhibitor blocks all three transporters at once, so norepinephrine, dopamine, and serotonin persist longer in the synapse and produce a more sustained effect on their receptors. This broad approach contrasts with single- or dual-transporter inhibitors used in mood and attention disorders, which raise only one or two of these neurotransmitters. Because dopamine and norepinephrine signaling in specific brain circuits influence appetite, energy expenditure, and reward, while serotonin contributes to satiety and mood regulation, drugs with this triple profile have been studied mainly in the context of appetite suppression and weight management, alongside historical interest in depression. The rationale for combining all three transporters, rather than one, is that appetite and energy balance are governed by overlapping monoaminergic circuits, and simultaneous modulation may produce effects that a narrower agent cannot achieve alone.